Skip navigation
Go to Global Navigation
Go to Primary Contents
Go to Site Information

YOKOGAWA

Yokogawa Electric Corporation

Our Commitment

How we prove it

Proof Stories


Dr.Patrick Yeung
Executive Project Director
Schering-Plough LTD,Singapore

"Yokogawa is an excellent company to work with. They distinguished themselves through their strong commitment to customer service, meeting and quite often exceeding customers' expectations," commented Dr. Patrick Yeung, Executive Director Projects of Schering-Plough Singapore.

A convincing endorsement of Yokogawa's leadership in the industry, Schering-Plough has once again opted for Yokogawa's latest DCS - CENTUM CS3000 for their recent plant expansion at Tuas, Multi-Products Plant (MPP) Project in Singapore. This new plant, the largest manufacturing facility for Schering-Plough outside USA, is designed to double their capacity, and it includes R&D activities in chemical processing. The Tuas plant utilizes state-of-the-art equipment for Active Pharmaceutical Ingredients (API) manufacture, and the MPP project offered Yokogawa real prestige to be associated with the latest blockbuster drug production such as Zetia for cholesterol management. The other key products manufactured using Yokogawa process automation solutions include 15 types of Steroids and four main categories of Synthesis - Anti-histamines, Anti-Asthma and Heart related.

Schering-Plough qualified Yokogawa because of its experience and expertise to fully execute and deliver Pharmaceutical Plant automation solution entirely by its local organization. Indeed, Yokogawa's commitment to quality and fulfillment with local expertise are the key drivers in ensuring the project success.

The demanding nature of pharmaceutical production business calls for strong corporate leadership, responsive R&D, dedicated employees, discipline in execution, high level of quality assurance process and comprehensive change management methodology. Yokogawa is able to provide unwavering support to assist customer in meeting FDA regulatory requirements, particularly in areas of electronic documentation and electronic signature. An elegant solution, the technological advantage of CENTUM CS3000 in providing extensive audit trails for operations as well as configuration management is critical for Schering-Plough to gain FDA approval for drug production in a highly integrated and automated plant.

"Yokogawa CENTUM System is a very good control system. With its installation, it certainly created an environment with much more control and reliability of processes, thus reducing the risk of errors and mistakes by our people and therefore have a greater assurance of quality of our products," said Dr Patrick Yeung. "We are very happy working with Yokogawa, to a point where we have continued to rely on Yokogawa to help us design and develop control systems for our new and very important expansion projects."


SYSTEM DETAILS

Systems: CENTUM CS 3000
Configuration: x9 FCS, 6000 I/O, x25 HIS and x2 EGS

IA Movie Center

Please check out the Industrial Automation & Control Business Movie Center.